米国は5月11日(木)以降は、「何を」「どの方法」「どの指標」でMonitor続けるかをAnnounceしました。
これはCDCが責任を持ってMonitorしていくという事です。
![COVID-19 Surveillance After Expiration of the Public ...]()
///////////////////////////////////////////////////
青字が測定対象、下線が目的
Monitoring the impact of COVID-19 and the effectiveness of prevention and control strategies remains a public health priority, and a number of surveillance indicators have been identified to facilitate ongoing monitoring.
COVID-19–associated hospital admission levels will be the primary indicator of COVID-19 trends to help guide community and personal decisions related to risk and prevention behaviors;
the percentage of COVID-19–associated deaths among all reported deaths, based on provisional death certificate data, will be the primary indicator used to monitor COVID-19 mortality.
Emergency department (ED) visits with a COVID-19 diagnosis and the percentage of positive SARS-CoV-2 test results, derived from an established sentinel network, will help detect early changes in trends.
National genomic surveillance will continue to be used to estimate SARS-CoV-2 variant proportions; wastewater surveillance and traveler-based genomic surveillance will also continue to be used to monitor SARS-CoV-2 variants.
Disease severity and hospitalization-related outcomes are monitored via sentinel surveillance and large health care databases.
Monitoring of COVID-19 vaccination coverage, vaccine effectiveness (VE), and vaccine safety will also continue.
Integrated strategies for surveillance of COVID-19 and other respiratory viruses can further guide prevention efforts.
これはCDCが責任を持ってMonitorしていくという事です。
COVID-19 Surveillance After Expiration of the Public ...
This report describes COVID-19 surveillance after the expiration of the U.S. Public Health Emergency declaration.
Centers for Disease Control and Prevention
///////////////////////////////////////////////////
青字が測定対象、下線が目的
Monitoring the impact of COVID-19 and the effectiveness of prevention and control strategies remains a public health priority, and a number of surveillance indicators have been identified to facilitate ongoing monitoring.
COVID-19–associated hospital admission levels will be the primary indicator of COVID-19 trends to help guide community and personal decisions related to risk and prevention behaviors;
the percentage of COVID-19–associated deaths among all reported deaths, based on provisional death certificate data, will be the primary indicator used to monitor COVID-19 mortality.
Emergency department (ED) visits with a COVID-19 diagnosis and the percentage of positive SARS-CoV-2 test results, derived from an established sentinel network, will help detect early changes in trends.
National genomic surveillance will continue to be used to estimate SARS-CoV-2 variant proportions; wastewater surveillance and traveler-based genomic surveillance will also continue to be used to monitor SARS-CoV-2 variants.
Disease severity and hospitalization-related outcomes are monitored via sentinel surveillance and large health care databases.
Monitoring of COVID-19 vaccination coverage, vaccine effectiveness (VE), and vaccine safety will also continue.
Integrated strategies for surveillance of COVID-19 and other respiratory viruses can further guide prevention efforts.